Pirfenidone

IDrugs. 2004 Feb;7(2):166-72.

Abstract

Pirfenidone, an antifibrotic tissue growth antagonist, is in development for the potential treatment of fibrotic diseases including renal, liver and pulmonary fibrosis and for multiple sclerosis.

Publication types

  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Fibrosis / drug therapy*
  • Humans
  • Pyridones / adverse effects
  • Pyridones / pharmacokinetics
  • Pyridones / pharmacology
  • Pyridones / therapeutic use*
  • Structure-Activity Relationship

Substances

  • Pyridones
  • pirfenidone